Paid
INFECTIS - Steam Copies Sold & Revenue Statistics
Game information
Game information
Total GrossTotal Net
$10K>$5K
Copies Sold
>1K
New owners
May 2026
Only for membersSales
Category Ranking History -
Owners
Steam Copies Sold & Revenue by Player Language
Game context & FAQ
Steam list price (this language tier)
USD storefront tier (default international): $12.99. USD reference tier: $12.99.
Quick answers
- What Steam list-price tier does GameSensor mirror for INFECTIS on this localized page?
- Our snapshot on 2026-06-06 shows about $12.99 for the storefront tier paired with this language view, alongside a USD tier of $12.99. Those are informational list tiers before VAT or running discounts.
- How are Steam copies sold and gross revenue computed?
- They’re modeled estimates from Steam review throughput, inferred player languages, historical price ladders per currency, and whether the SKU was temporarily free-not official Valve financials. See the indie methodology guide for formulas.
- Where do I find language mix data for INFECTIS?
- Look for “Steam Copies Sold & Revenue by Player Language” above; it breaks review volume down by Steam’s detected languages, which also drives our regional revenue weighting.
Information
INFECTIS was released on Steam on October 7, 2019 and has been available for 8 months.
According to GameSensor analytics, in May 2026, the game sold >1K copies, generating a total Steam revenue of >$5K. These numbers reflect strong interest from players and steady commercial performance.
This is the 4th title released by Aegon Games Ltd, demonstrating consistent production output and a stable release cycle.
A key factor driving the performance of INFECTIS is its international audience. The Steam player-language distribution shows that users primarily play the game in:
• English
• Traditional Chinese
• Russian.
Language distribution directly affects buying behavior, regional sales peaks, and long-term retention. Games with a diverse multilingual audience usually demonstrate stronger global performance and broader revenue stability.
The current Steam user rating for INFECTIS is moderately.
Compared to the studio’s previous release - The Rodinia Project - the game currently holds a higher rating. Its sales performance is 176% lower relative to The Rodinia Project over the same number of days after release.
Overall, sales are 395% lower compared to the average performance of the last 4 paid titles released by Aegon Games Ltd. This comparison helps position INFECTIS within the studio’s broader commercial history.
Within the full catalog of the publisher Aegon Games Ltd, INFECTIS currently ranks 3 among the most financially successful projects
Only game sales are included in the calculations, DLC sales and in-app purchases are excluded.
INFECTIS: the storefront tied to USD storefront tier (default international) shows $12.99 as of 2026-06-06, with USD reference $12.99. We plug these tracked tiers into the review-based gross model.